Showing results (91-100 of 157) with videos related to
Sort By:
Pageof 16
The Journal of Clinical Endocrinology and Metabolism|February 1, 1994
Urine hCG beta-subunit core fragment, a sensitive test for ectopic pregnancyL A Cole, A Kardana, D B Seifer, et al.American Journal of Obstetrics and Gynecology|May 1, 1993
Selecting human chorionic gonadotropin immunoassays: consideration of cross-reacting molecules in first-trimester pregnancy serum and urineL A Cole, D B Seifer, A Kardana, et al.British Journal of Cancer|May 2, 2000
The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferationS A Butler, M S Ikram, S Mathieu, et al.The Journal of Urology|September 1, 1975
Urologic manifestations of paroxysmal nocturnal hemoglobinuriaV Braren, S A Butler, R C Hartmann, et al.Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|April 10, 2009
Intraoperative haemostasis with new fibrin surgical sealant (Quixil) in gynaecological oncologyE N Papacharalabous, T Giannopoulos, A Tailor, et al.Prenatal Diagnosis|August 1, 1997
A demographic approach to the assessment of Down syndrome screening performanceW J van der Veen, J R Beekhuis, M C Cornel, et al.Prenatal Diagnosis|March 27, 1998
Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm deliveryL P Morssink, L H Kornman, T W Hallahan, et al.Prenatal Diagnosis|October 4, 2000
Trends in live birth prevalence of down syndrome in the Northern Netherlands 1987-96: the impact of screening and prenatal diagnosisM J Wortelboer, B T De Wolf, C C Verschuuren-Bemelmans, et al.Prenatal Diagnosis|February 1, 1997
Maternal urinary beta-core hCG in chromosomally abnormal pregnancies in the first trimesterL H Kornman, L P Morssink, M J Wortelboer, et al.Gynecologic Oncology|March 1, 1990
Urinary gonadotropin fragment, a new tumor marker. II. Differentiating a benign from a malignant pelvic massL A Cole, J H Nam, J T Chambers, et al.Pageof 16